Brant Point Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.82M | Buy |
|
|||||
|
2023
Q3 | $2.07M | Sell |
|
|||||
|
2023
Q2 | $2.97M | Sell |
|
|||||
|
2023
Q1 | $2.86M | Sell |
|
|||||
|
2022
Q4 | $4.2M | Sell |
|
|||||
|
2022
Q3 | $4.25M | Buy |
|
|||||
|
2022
Q2 | $3.23M | Sell |
|
|||||
|
2022
Q1 | $6.25M | Buy |
|
|||||
|
2021
Q4 | $5.69M | Buy |
|
|||||
|
2021
Q3 | $6.21M | Buy |
|
|||||
|
2021
Q2 | $5.55M | Hold |
|
|||||
|
2021
Q1 | $4.35M | Hold |
|
|||||
|
2020
Q4 | $3.75M | Buy |
|
|||||
|
2020
Q3 | $1.13M | Hold |
|
|||||
|
2020
Q2 | $872K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.88M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $4.19M | Sell |
|
|||||
|
2017
Q2 | $5M | Sell |
|
|||||
|
2017
Q1 | $6.13M | Buy |
|